Saint Cloud
France
16
2023-08-24
The entities that hold a legal rights for patent applications filed by inventor GAUDIN Christophe:
Christophe GAUDIN from Saint Cloud, FR has applied for patents for these inventions. The list has both pending applications and granted patents:
SLOW RELEASE PLASMINOGEN ACTIVATOR FORMULATION FOR USE IN THE TREATMENT OF THROMBOTIC OR HAEMORRHAGIC DISEASE
#2 | 2021-09-02USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY
#3 | 2019-02-14USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY
#4 | 2017-09-28USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY
#5 | 2015-11-19USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY
#6 | 2013-08-22Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of morality
#7 | 2012-12-27USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR THE PREPARATION OF A MEDICAMENT FOR ADMINISTRATION SHORTLY AFTER AMIODARONE DISCONTINUATION
#8 | 2012-10-04USE OF IRBESARTAN FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION OF HOSPITALIZATION FOR HEART FAILURE
#9 | 2011-09-22USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION OF STROKE OR TRANSIENT ISCHEMIC ATTACK
#10 | 2011-09-15USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY
#11 | 2011-09-01USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY
#12 | 2011-08-25USE OF CELIVARONE FOR REDUCING OCCURRENCES OF CARDIOVASCULAR HOSPITALIZATION
#13 | 2011-07-07USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVERSION
#14 | 2011-05-26USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR THE PREPARATION OF A MEDICAMENT FOR REGULATING THE POTASIUM LEVEL IN THE BLOOD
#15 | 2010-02-25Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality
#16 | 2010-01-21USE OF DRONEDARONE FOR THE TREATMENT OF PATIENTS WITH ARRHYTHMIA AND HAVING AN INCREASE OF CREATININE LEVEL DUE TO DRONEDARONE ADMINISTRATION
403591 ⎘